Role of exendin-4 in the Gila monster: Further lessons regarding human oral glucagon-like peptide-1 therapy?

Diabetes Obes Metab. 2020 Dec;22(12):2509-2511. doi: 10.1111/dom.14171. Epub 2020 Sep 14.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Exenatide
  • Glucagon-Like Peptide 1*
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Lizards*
  • Peptide Fragments
  • Peptides
  • Venoms

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Peptide Fragments
  • Peptides
  • Venoms
  • Glucagon-Like Peptide 1
  • Exenatide